Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment

T. Matsumoto, H. Wada, H. Toyoda, M. Hirayama, Y. Yamashita, N. Katayama
  • Journal of Thrombosis and Haemostasis, June 2018, Wiley
  • DOI: 10.1111/jth.14190

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Hideo Wada

In partnership with: